ATAI Life Sciences N.V (ATAI) concluded trading on Thursday at a closing price of $1.35, with 4.65 million shares of worth about $6.28 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -34.15% during that period and on November 07, 2024 the price saw a gain of about 14.41%. Currently the company’s common shares owned by public are about 166.03M shares, out of which, 117.07M shares are available for trading.
Stock saw a price change of 27.36% in past 5 days and over the past one month there was a price change of 23.85%. Year-to-date (YTD), ATAI shares are showing a performance of -4.26% which increased to 3.85% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.02 but also hit the highest price of $2.85 during that period. The average intraday trading volume for ATAI Life Sciences N.V shares is 631.23K. The stock is currently trading 16.08% above its 20-day simple moving average (SMA20), while that difference is up 14.08% for SMA50 and it goes to -13.97% lower than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ATAI Life Sciences N.V (NASDAQ: ATAI) currently have 166.03M outstanding shares and institutions hold larger chunk of about 7.43% of that.
The stock has a current market capitalization of $226.53M and its 3Y-monthly beta is at 0.83. It has posted earnings per share of -$0.36 in the same period. It has Quick Ratio of 6.68 while making debt-to-equity ratio of 0.10. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ATAI, volatility over the week remained 10.34% while standing at 8.81% over the month.
Stock’s fiscal year EPS is expected to drop by -222.86% while it is estimated to increase by 15.55% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Maxim Group on April 03, 2024 offering a Buy rating for the stock and assigned a target price of $6 to it. Coverage by Loop Capital stated ATAI Life Sciences N.V (ATAI) stock as a Buy in their note to investors on November 01, 2022, suggesting a price target of $18 for the stock. On November 30, 2021, Maxim Group Initiated their recommendations, while on November 11, 2021, ROTH Capital Initiated their ratings for the stock with a price target of $32. Stock get a Buy rating from H.C. Wainwright on October 18, 2021.
